If You Thought Obamacare Would Be A Big Subsidy To Pharmaceuticals, Just Watch What's About To Happen In China

The new healthcare bill will levy a tax on big pharma, but they’ll be fine because of all the new customers coming on line.

But that ain’t nothing compared to this…

From a note put out today by UBS:

Pharma- with the Chinese gov’t in the midst of vastly expanding h/c access for the entire population, the Chinese pharma mkt is growing 25-30% per annum. We expect the Chinese pharma mkt to grow from $30.4b in 09 to $102.8b in 2015. China will add more to world pharma than US, Western Europe, and Japan combined. Best Positioned- AZN, Novo Nordisk, PFE and Sanofi. Sent Note

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.